Abstract:Objective Congenital heart disease (CHD) is the most common birth defect in humans. The genetic causes for CHD remain largely unknown. Tetralogy of Fallot (TOF) is one major component of conotruncal defects (CTD), a complex CHD induced by abnormal development of the outflow tract. Retinoid X receptor alpha (RXRA), a ligand-dependent transcript factor, plays a critical role in multiple aspects of cardiogenesis including the development of outflow tract (OFT). Taken together, RXRA may be a potential candidate gene of TOF. To date, RXRA gene promoter region has not been analyzed and reported in TOF patients. We hypothesized that the sequence variants within RXRA gene promoter region may change RXRA levels and the development of TOF. In this study, the promoter regions of RXRA gene were genetically analyzed.Methods Case group included DNA samples from patients with TOF, which had been confirmed by cardiac catheterization and surgery. Control group consisted of DNA samples from randomly selected healthy children. Genomic DNA was extracted from peripheral blood. PCR was used to amplify the 1 417 bp promoter region from genomic DNA. PCR products were sequenced by ABI Prism Bigdye system.Results The promoter regions of RXRA gene were genetically analyzed in 213 TOF patients and 500 healthy controls. One novel heterozygous mutation, -1 191A>AG (according to the transcription start site), was found in one TOF patients, but in none of controls. Three novel single-nucleotide polymorphisms, -1287C>CT, -800C>CA and -760C>CT were found in both TOF patients and controls. There were no statistically significant changes in the genotype and allele frequencies of the three SNPs between TOF patients and control group (P>0.05). Several transcription factor binding sites were found within the region containing these single-nucleotide variations by searching http://www.cbrc.jp/research/db/TFSEARCH.html. Conclusions The A at position -1 191 following C, and C at position -800 was followed by G, thus these single-nucleotide variations provided additional candidate cytosines (CpG) for methylation that may enhance the level of gene expression.The sequence variants within RXRA gene promoter may contribute to the TOF etiology by altering the expression levels of RXRA gene.

Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification

Identification and Functional Validation of Variants in the Promoter Region of HAND1 Gene in Sporadic Tetralogy of Fallot

Tetralogy of Fallot: Variants of MYH6 Gene Promoter and Cellular Functional Analyses

Genetic Variants of ISL1 Gene Promoter Identified from Congenital Tetralogy of Fallot Patients Alter Cellular Function Forming Disease Basis

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

Genetic Variants of CITED2 Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification

DNA Sequencing of TGFβ2 in Sporadic Patients with Tetralogy of Fallot.

Identification and Functional Verification of CITED2 Gene Promoter Region in Patients with Patent Ductus Arteriosus.

Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot

Somatic Gata5 Mutations In Sporadic Tetralogy Of Fallot

Identification of novel rare copy number variants associated with sporadic tetralogy of Fallot and clinical implications

Gata5 Loss-Of-Function Mutations Underlie Tetralogy Of Fallot

Genetic analysis of the RXRA gene promoter in tetralogy of Fallot patients

Genetic Analysis of the CITED2 Gene Promoter in Isolated and Sporadic Congenital Ventricular Septal Defects.

Identification of Novel Significant Variants of ZFPM2/FOG2 in Non-Syndromic Tetralogy of Fallot and Double Outlet Right Ventricle in a Chinese Han Population

Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the GPR98 Locus on 5q14.3

A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.

The Role of Histone Modification and a Regulatory Single-Nucleotide Polymorphism (rs2071166) in the Cx43 Promoter in Patients with TOF.

Methylation Status of CpG Sites in the NOTCH4 Promoter Region Regulates NOTCH4 Expression in Patients with Tetralogy of Fallot.

Novel Missense Variants of ZFPM2/FOG2 Identified in Conotruncal Heart Defect Patients Do Not Impair Interaction with GATA4.

Variants and Cellular Functional Verification of CITED2 Gene Promoter Region in Patients with Atrial Septal Defect